Ekso Bionics Holdings IncNASDAQ:EKSO
- LAST PRICE1.1800
- TODAY'S CHANGE (%)0.0200 (1.7241%)
- Bid / Lots1.1600/ 2
- Ask / Lots1.2300/ 3
- Open / Previous Close1.1600 / 1.1600
- Day Range
- 52 Week Range
- Volume25,894
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EKSO |
|---|---|---|
| 09:32 ET | 3719 | 1.198 |
| 09:36 ET | 608 | 1.2184 |
| 09:45 ET | 200 | 1.19 |
| 10:01 ET | 377 | 1.213 |
| 10:19 ET | 175 | 1.2199 |
| 10:35 ET | 100 | 1.18 |
| 10:44 ET | 100 | 1.195 |
| 10:51 ET | 710 | 1.1883 |
| 11:13 ET | 1140 | 1.19 |
| 12:57 ET | 1300 | 1.21 |
| 01:06 ET | 907 | 1.2154 |
| 01:42 ET | 100 | 1.2 |
| 02:27 ET | 240 | 1.205 |
| 02:36 ET | 1900 | 1.2 |
| 02:49 ET | 3980 | 1.1901 |
| 02:51 ET | 2400 | 1.19 |
| 02:58 ET | 4206 | 1.19 |
| 03:38 ET | 175 | 1.19 |
| 03:43 ET | 300 | 1.21 |
| 03:59 ET | 1632 | 1.18 |
Apr 22, 2024
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024, from 8:00AM ET on Monday Apr 22, 2024 by Dow Jones
8:00AM ET on Monday Apr 22, 2024 by Dow Jones
Apr 12, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ekso Bionics Holdings Inc | 20.8M | -1.1x | --- |
Spectral AI Inc | 32.0M | -1.2x | --- |
Micron Solutions Inc | 4.0M | -1.7x | --- |
Prosomnus Inc | 3.0M | -0.2x | --- |
ICAD Inc | 41.4M | -5.7x | --- |
Precipio Inc | 8.8M | -1.2x | --- |
Company Information
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
Contact Information
- Headquarters
- 101 GLACIER POINT, SUITE ASAN RAFAEL, CA, United States 94901
- Phone
- 510-984-1761
- Fax
- 702-866-2689
Executives
- President, Chief Operating Officer
- Scott Davis
- Chief Financial Officer, Corporate Secretary
- Jerome Wong
- Chief Operating Officer
- Jason Jones
- Independent Director
- Mary Cloyd
- Independent Director
- Corinna Lathan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.8M |
|---|---|
Revenue (TTM) | $18.3M |
Shares Outstanding | 17.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-1.10 |
Book Value | $0.85 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -82.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
